Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Shrimanker has nothing to disclose.
Conflict of interest: Dr. Pavord reports personal fees from AstraZeneca, personal fees from GSK, personal fees from Boehringer Ingelheim, grants and personal fees from Chiesi, personal fees from Sanofi/Regeneron, personal fees from Circassia, personal fees from Merck, personal fees from Novartis, personal fees from Mundipharma, personal fees from Teva, personal fees from Knopp, grants and personal fees from Afferent, personal fees from Roche/Genentech, outside the submitted work.
Conflict of interest: Dr. Yancey reports other from GSK, during the conduct of the study; other from GSK, outside the submitted work.
Conflict of interest: Professor Green reports personal fees from Astra Zeneca, personal fees from Novartis, outside the submitted work.
Conflict of interest: Dr. Bradding reports non-financial support from GSK, during the conduct of the study.
Conflict of interest: Dr. Hargadon has nothing to disclose.
Conflict of interest: Dr. brightling reports grants from GSK, grants from NIHR, during the conduct of the study; grants and personal fees from AZ/MedImmune, grants and personal fees from GSK, grants and personal fees from BI, grants and personal fees from Chiesi, grants and personal fees from Novartis, personal fees from Glenmark, personal fees from Gilead, personal fees from TEVA, grants and personal fees from Roche/Genentech, personal fees from Sanofi, personal fees from Regeneron, personal fees from 4DPharma, personal fees from PreP, grants from Mologic, outside the submitted work.
Conflict of interest: Dr. Wardlaw reports grants from Glaxo Smith Kline, during the conduct of the study; grants from Pulmocide, personal fees from GSK, personal fees from Astra Zeneca/MedImmune, personal fees from TEVA, personal fees from GfK, outside the submitted work.
Conflict of interest: Dr. Haldar has nothing to disclose.
Conflict of interest: Dr. Heaney reports other from AstraZeneca, Boehringer Ingelheim, GSK and Napp Pharmaceuticals, personal fees from Novartis, Roche/Genentech Inc, Sanofi, Glaxo Smith Kline, Amgen, Astra Zeneca, Aerocrine, outside the submitted work.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018